Switch to:
GuruFocus has detected 2 Warning Signs with Alexion Pharmaceuticals Inc $ALXN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Alexion Pharmaceuticals Inc (NAS:ALXN)
EV-to-EBITDA
26.90 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Alexion Pharmaceuticals Inc's enterprise value is $30,167 Mil. Alexion Pharmaceuticals Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2017 was $1,122 Mil. Therefore, Alexion Pharmaceuticals Inc's EV/EBITDA ratio for today is 26.90.

ALXN' s EV-to-EBITDA Range Over the Past 10 Years
Min: -145   Max: 258.3
Current: 26.9

-145
258.3

During the past 13 years, the highest EV/EBITDA Ratio of Alexion Pharmaceuticals Inc was 258.30. The lowest was -145.00. And the median was 42.05.

ALXN's EV-to-EBITDA is ranked lower than
61% of the 281 Companies
in the Global Biotechnology industry.

( Industry Median: 18.28 vs. ALXN: 26.90 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Alexion Pharmaceuticals Inc's stock price is $126.23. Alexion Pharmaceuticals Inc's earnings per share for the trailing twelve months (TTM) ended in Mar. 2017 was $2.09. Therefore, Alexion Pharmaceuticals Inc's P/E Ratio for today is 60.40.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Alexion Pharmaceuticals Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=30166.772/1121.512
=26.90

Alexion Pharmaceuticals Inc's current Enterprise Value is $30,167 Mil.
Alexion Pharmaceuticals Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2017 was 291.337 (Jun. 2016 ) + 283.601 (Sep. 2016 ) + 229.574 (Dec. 2016 ) + 317 (Mar. 2017 ) = $1,122 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Alexion Pharmaceuticals Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=126.23/2.09
=60.40

Alexion Pharmaceuticals Inc's share price for today is $126.23.
Alexion Pharmaceuticals Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2017 was 0.51 (Jun. 2016 ) + 0.42 (Sep. 2016 ) + 0.41 (Dec. 2016 ) + 0.75 (Mar. 2017 ) = $2.09.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Alexion Pharmaceuticals Inc Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
ev2ebitda -34.1863.1943.3642.3851.2940.6044.3638.0063.4327.51

Alexion Pharmaceuticals Inc Quarterly Data

Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16Mar17
ev2ebitda 38.0040.1454.9350.3563.4339.2129.6428.7127.5125.96
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK